Elevated prolactin in pediatric patients on typical and atypical antipsychotics.

@article{Wudarsky1999ElevatedPI,
  title={Elevated prolactin in pediatric patients on typical and atypical antipsychotics.},
  author={Marianne Wudarsky and Rob Nicolson and Susan D. Hamburger and L Spechler and Peter A. Gochman and J. Bedwell and Marge C Lenane and Judith L. Rapoport},
  journal={Journal of child and adolescent psychopharmacology},
  year={1999},
  volume={9 4},
  pages={
          239-45
        }
}
As part of systematic treatment trials of haloperidol, clozapine, and olanzapine with a total of 35 children and adolescents with early onset psychosis, prolactin was measured at baseline and week 6 of treatment. The National Institute of Mental Health patients--13 females, 22 males (mean age, 14.1+/-2.3 years; range, 9.1-19 years) with childhood onset schizophrenia (n = 32), or Psychotic Disorder not otherwise specified (NOS) (n = 3) with onset of psychosis before age 13--were recruited for… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 38 CITATIONS

Clinical and Laboratory Characteristics of Hyperprolactinemia in Children and Adolescents: National Survey

  • Journal of clinical research in pediatric endocrinology
  • 2018
VIEW 1 EXCERPT
CITES BACKGROUND

Harms of Antipsychotics in Children and Young Adults: A Systematic Review Update.

  • Canadian journal of psychiatry. Revue canadienne de psychiatrie
  • 2018
VIEW 1 EXCERPT
CITES BACKGROUND